MDCT appearance of gastrointestinal stromal tumors after therapy with imatinib mesylate.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 16423961.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Our objective was to determine the MDCT appearance of gastrointestinal stromal tumors (GISTs) after treatment with imatinib mesylate. Cystic changes within primary and metastatic GISTs seen on MDCT in patients after imatinib mesylate therapy are evidence of disease response. Calcification may also occur in lesions that respond to therapy.
Medical subject headings
- Gastrointestinal Stromal Tumors
- Piperazines
- Protein Kinase Inhibitors
- Pyrimidines
- Tomography, X-Ray Computed